Skip to Main Content

Paper Details

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor.
NPJ Precis Oncol
18
2021
MAPK, MEK, MPNST, malignant peripheral nerve sheath tumor, malignant peripheral nerve sheath tumors, mitogen-activated protein kinase, patient
Author NameAffiliation
Glenn M MarshallKids Cancer Centre, Sydney Children's Hospital
Glenn M Marshall
Glenn M MarshallChildren's Cancer Institute, Lowy Cancer Research Centre
Vanessa TyrrellChildren's Cancer Institute, Lowy Cancer Research Centre
Vanessa TyrrellChildren's Cancer Institute, Lowy Cancer Research Centre
Paul G Ekert
Paul G EkertChildren's Cancer Institute, Lowy Cancer Research Centre
Mark J Cowley
Mark J CowleyChildren's Cancer Institute, Lowy Cancer Research Centre
Chelsea Mayoh
Chelsea MayohChildren's Cancer Institute, Lowy Cancer Research Centre
David S ZieglerKids Cancer Centre, Sydney Children's Hospital
David S Ziegler
David S ZieglerChildren's Cancer Institute, Lowy Cancer Research Centre
  • 1 - 14

Datasets

Release 1.2